News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Broadcom shares slipped into oversold territory after leaders of major AI customers urged a pause on rapid AI rollout.
  • Broadcom's $16.7 billion AI chip revenue run-rate and $39.4 billion free cash flow indicate look-through demand remains.
  • A mid-term buy-the-dip trade idea outlines entry, stop, and target with catalysts and balanced risks.
  • Star Bulk raised about €107.8 million ($124.4 million) via a public offering and parallel private placing.
  • The company will use proceeds to complete three vessels under construction and finance additional vessel acquisitions.
  • Treasury Secretary Scott Bessent said the U.S. provided only nominal support in the coordinated yen intervention.

Latest Articles

Market Discounts SoftBank Over Leverage, Not Portfolio Quality

Market Discounts SoftBank Over Leverage, Not Portfolio Quality

SoftBank Group posted a record net asset value of ¥72.3T on Jun 30, then saw that NAV fall by nearly ¥14T to ¥58.3T by Aug 5 while its share price remains deeply discounted to stated NAV. The disconnect between rising paper gains and a collapsing share price reflects market concern about the debt and short-term financing SoftBank has taken on to fu…

KOSPI Retreats as AI-Led Rally Unwinds After 33% Peak Drop

KOSPI Retreats as AI-Led Rally Unwinds After 33% Peak Drop

The KOSPI has surrendered a large portion of its recent gains amid a sharp monthly and weekly pullback, yet remains well above last year’s lows. Heavy index concentration in Samsung and SK Hynix, coupled with a retail-driven leveraged ETF surge and a blowup in AI sentiment following disappointing guidance from an industry peer, has turned what was …

IMC Rare Earths Ltd Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

IMC Rare Earths Ltd Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

IMC Rare Earths Ltd successfully completed its IPO on the NYSE American, with underwriters exercising their option to purchase an additional 600,000 shares at $5.00 each, raising approximately $3 million more. The total gross proceeds from the upsized offering amount to $23 million which will be used for working capital, exploration, development, l…

Dorchester Minerals, L.P. Announces Second Quarter Results

Dorchester Minerals, L.P. Announces Second Quarter Results

Dorchester Minerals, L.P. reported a robust financial performance for the second quarter ended June 30, 2026, with net income rising to $30.9 million, or $0.62 per common unit, compared to $12.3 million, or $0.25 per unit, in the same quarter last year. Operating revenues also increased substantially to $56.1 million from $32.4 million. The partner…

Ticketplus Announces Pricing of Initial Public Offering

Ticketplus Announces Pricing of Initial Public Offering

Ticketplus Ltd., a Chile-based technology company serving live entertainment across Latin America, announced the pricing of its initial public offering of 1,875,000 ordinary shares at $8.00 per share, raising approximately $15 million before expenses. The shares will begin trading on the NYSE American under the ticker TP on August 7, 2026, with an …

Tango Therapeutics Announces Executive Chair Transition

Tango Therapeutics Announces Executive Chair Transition

Tango Therapeutics announced that Dr. Barbara Weber will step down as Executive Chairman of the Board to pursue other interests. The company, focused on precision cancer medicines using synthetic lethality, expressed gratitude for her leadership while reaffirming confidence in its future progress.

Biogen Completes Acquisition of RayThera Inc.

Biogen Completes Acquisition of RayThera Inc.

Biogen Inc. has completed the acquisition of RayThera Inc., a private biotech focused on small-molecule immunology therapies, to enhance Biogen's immunology portfolio. This acquisition adds multiple assets targeting immune-mediated diseases, with the lead program having entered Phase 1 development recently. The move aligns with Biogen's strategy to…